IFOM

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IFOM was filed as Figurative mark on 09/20/2018 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Photography, cinematography, optics #Letters presenting a special form of writing #Binoculars, telescopes, field glasses, microscopes #Letters linked to a figurative element #Letters underlined, overlined, framed or barred by one or more strokes

Trademark Details Last update: May 17, 2023

Trademark form Figurative mark
File reference 1462161
Countries European Community India Japan Singapore United States of America (USA) Switzerland China
Base trademark IT No. 302018000015354, April 27, 2018
Application date September 20, 2018
Expiration date September 20, 2028

Trademark owner

Via Adamello, 16
I-20139 Milano (MI)
IT

Trademark representatives

Via Porlezza 12 I-20123 Milano (MI) IT

goods and services

05 Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of the skeletal system; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of the circulatory system; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of hormonal and diabetic disorders; pharmaceutical cough preparations; preparations for treating colds; pharmaceutical preparations for the treatment of flu and headache; pharmaceutical preparations for the treatment of stomach disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for treating muscolar and/or rheumatological diseases; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for use in oncology; diagnostic preparations and reagents for clinic or medical laboratory; hormones for medical purposes; dietetic substances adapted for medical use, in particular, nutritional supplements, vitamin preparations, herbal supplements and preparations, nutritional drink mixes for use as meal replacements for medical use, meal replacement snacks for medical purposes; food and drinks for babies, infant formula and dietetic products for invalids, in particular food for babies, powdered milk for babies, foods for enteral feedings and dietetic foods adapted for medical purposes
41 Education and instruction; organisation of seminars, arranging of conventions, courses, events, symposium for educational or cultural purposes; publishing services; publishing of scientific and informative publications, also online; dissemination of educational material in the field of scientific research; developing international student exchange programs
42 Scientific and technological services including research and development related thereto; scientific and industrial research and analysis; biological research and analysis; scientific, clinical and medical research; basic and clinical research in the field of genetics, stem cell, immunodeficiency and neurodegenerative diseases, proteomics, bioinformatics, neurobiology and molecular biology and diabetes; research in the field of medicine; consultancy in the field of scientific analysis
44 Medical services, health care services, medical assistance, physical rehabilitation; hospital services; consultancy in the field of medical diagnosis and analysis; consulting services relating to health care

Trademark history

Date Document number Area Entry
July 1, 2021 2021/30 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 1, 2020 2020/50 Gaz US Rejection
November 19, 2020 2020/48 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 11, 2020 2020/24 Gaz JP Rejection
March 13, 2020 2020/12 Gaz CH Rejection
November 22, 2019 2019/47 Gaz SG Rejection
November 18, 2019 2019/47 Gaz IN Rejection
September 25, 2019 2019/39 Gaz EM Rejection
June 18, 2019 2019/26 Gaz CN Rejection
May 31, 2019 2019/23 Gaz US Rejection
September 20, 2018 2019/14 Gaz IT Registration

ID: 141462161